# iBio, Inc.: Form 8-K, filed Nov 25, 2024

- Company: [iBio, Inc.](/companies/ibio.md) (CIK 1420720)
- Form: 8-K
- Filed: 2024-11-25
- Accepted by EDGAR: Nov 25, 2024, 08:30 ET
- Period: 2024-11-21
- Accession: 0001104659-24-122387
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420720/000110465924122387/tm2429233d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420720/000110465924122387/

## Items reported

- Item 2.02: Results of operations
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1420720/000110465924122387/tm2429233d1_8k.htm

Filed Nov 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-122387. Last ingested by Listed: Nov 11, 2026, 02:10 ET. No prices; not investment advice.